ロード中...
Lobaplatin for the treatment of SK-MES-1 lung squamous cell line in vitro and in vivo
Lung squamous cell carcinoma is the second-largest histological subtype of lung cancer, which is the leading cause of cancer-related death worldwide. Lobaplatin, one of the third-generation platinum compounds, has shown encouraging anticancer activity in a variety of tumors. The aim of this study wa...
保存先:
| 出版年: | Onco Targets Ther |
|---|---|
| 主要な著者: | , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Dove Medical Press
2016
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4948715/ https://ncbi.nlm.nih.gov/pubmed/27471396 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S108032 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|